AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+3.46%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$343M
AUM Growth
+$343M
(-13%)
Cap. Flow
-$57.3M
Cap. Flow
% of AUM
-16.69%
Top 10 Holdings %
Top 10 Hldgs %
78.35%
Holding
286
New
92
Increased
42
Reduced
67
Closed
66
Top Buys
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$1.83M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$1.27M |
| 3 |
GXO Logistics
GXO
|
$1.27M |
| 4 |
Intuitive Surgical
ISRG
|
$1.17M |
| 5 |
MP Materials
MP
|
$1.14M |
Top Sells
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$30.3M |
| 2 |
iShares MBS ETF
MBB
|
$29.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$1.86M |
| 4 |
Azenta
AZTA
|
$1.54M |
| 5 |
Synopsys
SNPS
|
$1.5M |
Sector Composition
| 1 | Real Estate | 24.12% |
| 2 | Healthcare | 12.62% |
| 3 | Technology | 1.66% |
| 4 | Financials | 1.65% |
| 5 | Industrials | 1.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Collegium Pharmaceutical
COLL
$1.22B
| $1.13M | 0.33% |
60,500
+23,500
| +64% | +$439K |
|
27
Aurora
AUR
$10.4B
| $1.13M | 0.33% |
+100,000
| New | +$1.13M |
|
|
MFA
28
MFA Financial
MFA
$1.05B
| $1.12M | 0.32% |
244,436
+30,000
| +14% | +$137K |
|
29
Arcutis Biotherapeutics
ARQT
$1.86B
| $1.09M | 0.32% |
52,500
+17,000
| +48% | +$353K |
|
|
RVNC
30
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.06M | 0.31% |
65,000
+58,500
| +900% | +$955K |
|
31
BioXcel Therapeutics
BTAI
$59M
| $1.02M | 0.3% |
50,000
+15,000
| +43% | +$305K |
|
32
Aclaris Therapeutics
ACRS
$209M
| $989K | 0.29% |
68,000
+17,000
| +33% | +$247K |
|
|
AERI
33
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $962K | 0.28% |
137,000
+89,500
| +188% | +$628K |
|
34
Mr. Cooper
COOP
$12.1B
| $948K | 0.28% |
22,794
| – | – |
|
35
AeroVironment
AVAV
$12.1B
| $930K | 0.27% |
15,000
| – | – |
|
|
SAFE
36
Safehold
SAFE
$1.18B
| $920K | 0.27% |
35,617
+5,338
| +18% | +$138K |
|
37
Karyopharm Therapeutics
KPTI
$61.7M
| $900K | 0.26% |
140,000
+4,000
| +3% | +$25.7K |
|
38
Procept Biorobotics
PRCT
$2.23B
| $875K | 0.26% |
35,000
+15,000
| +75% | +$375K |
|
|
ONIT
39
Onity Group Inc.
ONIT
$333M
| $858K | 0.25% |
21,477
| – | – |
|
40
AEye
LIDR
$113M
| $847K | 0.25% |
175,000
+75,000
| +75% | +$363K |
|
41
BioMarin Pharmaceuticals
BMRN
$11.2B
| $839K | 0.24% |
9,500
+1,500
| +19% | +$132K |
|
42
PennyMac Financial
PFSI
$5.69B
| $816K | 0.24% |
11,699
| – | – |
|
|
TPTX
43
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $811K | 0.24% |
+17,000
| New | +$811K |
|
44
Insmed
INSM
$28.8B
| $776K | 0.23% |
28,500
| – | – |
|
45
AdaptHealth
AHCO
$1.28B
| $770K | 0.22% |
31,500
+3,500
| +13% | +$85.6K |
|
46
Microbot Medical
MBOT
$185M
| $750K | 0.22% |
100,000
| – | – |
|
47
Bristol-Myers Squibb
BMY
$96B
| $748K | 0.22% |
12,000
+11,290
| +1,590% | +$704K |
|
|
TCRR
48
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $704K | 0.21% |
151,000
+38,000
| +34% | +$177K |
|
49
iTeos Therapeutics
ITOS
$449M
| $698K | 0.2% |
+15,000
| New | +$698K |
|
50
PTC Therapeutics
PTCT
$3.92B
| $697K | 0.2% |
17,500
+5,000
| +40% | +$199K |
|